Combating Tuberculosis: Bedaquiline, a new TB antibiotic, triumphs over multidrug-resistant strains.
Vous n'êtes pas connecté
A new antibiotic for tuberculosis (TB) targets multidrug-resistant strains, paving the way for advanced treatments and innovative drug development, according to Rutgers Health research.
Combating Tuberculosis: Bedaquiline, a new TB antibiotic, triumphs over multidrug-resistant strains.
Research Shows Alternative Treatment Regimens Against Drug-resistant TB With tuberculosis (TB) reemerging as the leading infectious disease killer in...
In a breakthrough for patients with multi-drug-resistant (MDR) tuberculosis (TB), researchers shared positive trial results for a shorter, tailored...
The biopharmaceutical field leads the way in science, researching and developing new treatments for health needs. In 2024, research and development in...
Scientists have discovered a way to target elusive circular fragments of DNA that drive the survival of some of the most aggressive cancers, paving...
All cancer mutations that cause drug resistance fall into one of four categories. New research has detailed each type, helping to uncover targets for...
We have just faced a global pandemic that has claimed more than 7 million lives. The Covid-19 disease was only successfully fought after a vaccine was...
Tuberculosis Resurges as Top Infectious Disease Killer By Joyce Ojanji In the highest tally ever recorded for tuberculosis (TB) cases, the World...
New lignin-based hydrogel represents a breakthrough in the fields of wound healing and drug delivery, offering innovative solutions for improved...
A virulent new strain of antibiotic-resistant bacteria that causes severe disease could be spreading widely across Asia - posing significant...